RT Journal Article
SR Electronic
T1 COVID-19 Serology Control Panel Using the Dried Tube Specimen Method
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.07.21260101
DO 10.1101/2021.07.07.21260101
A1 Windsor, William J.
A1 Knight, Vijaya
A1 Merkel, Patricia A.
A1 Lamb, Molly M.
A1 Santiago, Mario L.
A1 McCarthy, Mary K.
A1 Morrison, Thomas E.
A1 Kedl, Ross M.
A1 Frazer-Abel, Ashley
A1 Guo, Kejun
A1 Andersen, Gillian
A1 Huey, Leah
A1 Barrett, Bradley S.
A1 Colón-Franco, Jessica M.
A1 Chu, May C.
YR 2021
UL http://medrxiv.org/content/early/2021/08/18/2021.07.07.21260101.abstract
AB We used the dried tube specimen (DTS) procedure to develop the COVID-19 Serology Control Panel (CSCP). The CSCP contains five well-characterized SARS-CoV-2 pooled plasma samples made available for labs around the world to compare test kits, use for external quality assurance, harmonize laboratory testing, and train laboratory workers.Article Summary Line The dried tube specimen system is a highly effective and resilient way to provide laboratories with well-characterized serology materials. The CSCP can help clinical laboratories inform their choice of diagnostic test to supplement clinical diagnoses of SARS-CoV-2 infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported and funded by the Bill & Melinda Gates FoundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Colorado Multiple Institutional Review Board (COMIRB) https://research.cuanschutz.edu/comirbAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Data are available